This ICON/Trevi 1 year study aims to determine the evaluate the safety, tolerability, and effectiveness of nalbuphine as a treatment for the itching related to Prurigo Nodularis (PN). This study will also evaluate participant’s itch-related quality of life and sleep quality. There are currently no approved treatments specifically for people who experience itching due to Prurigo Nodularis.
To participate in your local study, please contact (949) 844-0442 or fill out the form below.
Protocol # TR-11
Share this post
Subscribe To Our Newsletter
Get updates and learn from the best
More To Explore
Call us, write us, or knock on our door.
Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.
- 27020 Alicia Parkway , Suite G Laguna Niguel, CA 92677
- Monday - Friday: 8AM - 5PM
- Saturday and Sunday: Closed
- (949) 707-5734
- info@avancetrials.com